Presence of CD34+CD38−CD58− leukemia-propagating cells at diagnosis identifies patients at high risk of relapse with Ph chromosome-positive ALL after allo-hematopoietic SCT - Kong, Y; Xu, L-P; Liu, Y-R; Qin, Y-Z; Sun, Y-Q; Wang, Y; Jiang, H; Jiang, Q; Chen, H; Chang, Y-J; Huang, X-J (Bone marrow transplantation (Basingstoke), 2015)
Keywords: 13/100; 13/31; 631/532/71; 692/699/1541/1990/283/2125; Acute Disease; Adolescent; ADP-ribosyl Cyclase 1 - metabolism; Adult; Antigens, CD34 - metabolism; BCR-ABL protein; BCR-ABL1 gene; Bone marrow; CD19 antigen; CD34 antigen; CD38 antigen; CD45 antigen; CD58 antigen; CD58 Antigens - metabolism; Cell Biology; Chromosomes; Diagnosis; Female; Flow cytometry; Hematology; Hematopoietic Stem Cell Transplantation - methods; Humans; Internal Medicine; Leukemia; Male; Medicine; Medicine & Public Health; Middle Aged; Minimal residual disease; original-article; Phenotypes; Precursor Cell Lymphoblastic Leukemia-Lymphoma - immunology; Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology; Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy; Public Health; Recurrence; Risk analysis; Risk Factors; Risk groups; Stem cell transplantation; Stem Cells; Transplantation Conditioning - methods; Xenografts; Xenotransplantation; Young Adult